ENDOSCOPIC AND HISTOLOGIC OUTCOME IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT

被引：0
|
作者：
Verstockt, Bram
Outtier, An
Lefrere, Jolien
Sabino, Joao
Vermeire, Severine
De Hertogh, Gert
Ferrante, Marc
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1858
引用
收藏
页码：S952 / S952
页数：1
相关论文
共 50 条
  • [21] Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
    Shin, Seung Hwan
    Oh, Kyunghwan
    Hong, Sung Noh
    Lee, Jungbok
    Oh, Shin Ju
    Kim, Eun Soo
    Na, Soo-Young
    Kang, Sang-Bum
    Koh, Seong-Joon
    Bang, Ki Bae
    Jung, Sung-Ae
    Jung, Sung Hoon
    Kim, Kyeong Ok
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Choi, Chang Hwan
    Ye, Byong Duk
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [22] Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: A KASID multicenter cohort study
    Oh, K.
    Hong, S. N.
    Kim, E. S.
    Na, S. Y.
    Kang, S. B.
    Koh, S. J.
    Bang, K. B.
    Jung, S. A.
    Kim, K. O.
    Choi, C. H.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S359 - S361
  • [23] Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
    Shin, Seung Hwan
    Oh, Kyunghwan
    Hong, Sung Noh
    Lee, Jungbok
    Oh, Shin Ju
    Kim, Eun Soo
    Na, Soo-Young
    Kang, Sang-Bum
    Koh, Seong-Joon
    Bang, Ki Bae
    Jung, Sung-Ae
    Jung, Sung Hoon
    Kim, Kyeong Ok
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Choi, Chang Hwan
    Ye, Byong Duk
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [24] Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia
    Hernandez Martinez, Alvaro
    Navajas Hernandez, Pilar
    Martin Rodriguez, Maria del Mar
    Lazaro Saez, Marta
    Olmedo Martin, Raul
    Nunez Ortiz, Andrea
    Arguelles Arias, Federico
    Fernandez Cano, Maria Carmen
    Gallardo Sanchez, Francisco
    Marin Pedrosa, Sandra
    Gonzalez Garcia, Javier
    Vazquez Moron, Juan Maria
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (09) : 516 - 521
  • [25] ETRASIMOD IMPROVES QUALITY OF LIFE IN ADULTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Taylor, Carly
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Schreiber, Stefan
    Naik, Snehal U.
    Rabbat, Christopher J.
    Akhundova-Unadkat, Gamar
    Sandborn, William J.
    GUT, 2022, 71 : A143 - A143
  • [26] Endoscopic and histologic outcomes in patients with moderate-to-severe Ulcerative Colitis treated with infliximab: A post hoc analysis of the Phase 3 LIBERTY-UC study
    Colombel, J. F.
    Hanauer, S. B.
    Schreiber, S.
    Danese, S.
    Deepak, P.
    Horst, S. N.
    Jeong, A. L.
    Kim, D. H.
    Lee, Y. N.
    Sands, B. E.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i78 - i79
  • [27] Tofacitinib in Moderate to Severe Ulcerative Colitis patients naive to biological therapy: A prospective real world analysis of efficacy and safety
    Banerjee, R.
    Dhanush, M.
    Raghunathan, N.
    Pal, P.
    Joshi, V.
    Patel, R.
    Godbole, S.
    Akki, Y.
    Valluri, S.
    Nagasuri, P.
    Haridas, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1323 - I1325
  • [28] Tofacitinib as salvage therapy for patients hospitalized with refractory severe active ulcerative colitis: a GETAID multicenter prospective/retrospective cohort
    Uzzan, M.
    Bresteau, C.
    Laharie, D.
    Stefanescu, C.
    Carbonnel, F.
    Serrero, M.
    Viennot, S.
    Nachury, M.
    Amiot, A.
    Altwegg, R.
    Picon, L.
    Nahon, S.
    Vuitton, L.
    Soune, P. Ah
    Kirchgesner, J.
    Peyrin-Biroulet, L.
    Bouhnik, Y.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S305 - S306
  • [29] Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort
    Bossuyt, Peter
    Baert, Filip
    D'Heygere, Francois
    Nakad, Antoine
    Reenaers, Catherine
    Fontaine, Fernand
    Franchimont, Denis
    Dewit, Olivier
    Van Hootegem, Philippe
    Vanden Branden, Stijn
    Lambrecht, Guy
    Ferrante, Marc
    Hindryckx, Pieter
    Macken, Elisabeth
    Caenepeel, Philip
    Vijverman, Anne
    de Suray, Nicolas
    Dutre, Joris
    Louis, Edouard
    Coenegracths, Jean-Louis
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (01) : 156 - 162
  • [30] Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
    Chiorean, Michael, V
    Allegretti, Jessica R.
    Sharma, Puza P.
    Chastek, Benjamin
    Salese, Leonardo
    Bell, Elizabeth J.
    Peterson-Brandt, Jesse
    Cappelleri, Joseph C.
    Guo, Xiang
    Khan, Nabeel
    BMC GASTROENTEROLOGY, 2022, 22 (01)
12345